Sanfetrinem cilexetil: Trinem antibacterial

Drugs of the Future

Volumn 21, Issue 12, 1996, Pages 1238-1245

  Ngo, J ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFACLOR; CEFPODOXIME; CEFPODOXIME PROXETIL; CEFTRIAXONE; CEFUROXIME AXETIL; CILASTATIN; CLARITHROMYCIN; CLAVULANIC ACID; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LORACARBEF; NAFCILLIN; PENICILLIN G; SANFETRINEM CILEXETIL; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LUNG INFECTION; NONHUMAN; ORAL DRUG ADMINISTRATION; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE;

EID: 0030499163     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.12.384902     Document Type: Article

References (33)

1. Hanessian, S., Rozema, M.J. A highly stereoselective and practical total synthesis of the tricyclic β-lactam antibiotic GV104326 (4-methoxytrinem). J Amer Chem Soc 1996. 118(41): 9884-91.
2. Perboni, A., Rossi, T., Gaviraghi, G., Ursini, A., Tarzia, G. (Glaxo SpA). 70(1-Hydroxyethyi-11 -oxo-1 -azatricyclo [7.2,0.0.3.8]undec-2-ene-2-carboxy/ic acid esters and a process for preparing there of JP 93502044, WO 9203437.
3. Bismara, C., Di Fabio, R., Donati, D., Rossi, T. Thomas, R.J. The synthesis of a key intermediate of tricyclic β-lactam antibiotics. Tetrahedron Lett 1995, 36(24): 4283-6.
4. Perboni, A., Bismara, C., Pentassuglia, G. (Glaxo SpA) Heterocyclic derivs. EP 466509.
5. Rossi, T., Biondi, S., Contini, S., Thomas, R.J., Marchioro, C. Novel amidoalkylation of 4-acetoxyazetidinones with allylic boranes. A stereoselective entry into the tribactams. J Amer Chem Soc 1995 117: 9604-5.
6. Rossi, S., Zarantonello, P., Thomas, J.R. (Glaxo SpA). Process for the preparation of cyclohexyl-azetidinones. WO 9526333.
7. Ghiron, C., Piga, E., Rossi, T., Tamburini, B., Thomas, R.J. The stereoselective synthesis of a key intermediate of the trinem antibiotic sanfetrinem. Tetrahedron Lett 1996, 37(22): 3891-4.
8. Tamburini, B., Perboni, A., Rossi, T., Donati, D., Andreotti, D., Gaviraghi, G., Cartesso, R., Bismarc, C., (Glaxo SpA). 10-(1-Hydroxyethyi) - 11 -oxo-1 -azatricyclo[7.2.0.0.3,8]undec-2-ene2-carboxylic acid derivs. AU 9162265, EP 416953, US 5407931.
9. Camerini, R., Panunzio, M., Bonanomi, G., Donati, D., Perboni, A. Highly stereocontrolled synthesis of a novel tribactam by reaction of an ester enolate with a N-trimethylsilylimine. Tetrahedron Lett 1996, 37(14): 2467-70.
10. Arduino, R.C., Murray, B.E Enterococcus: Antimicrobial resistance. In: Principles and Practices of Infectious Diseases. Vol. 2 G.L Mandell, R.G Douglas. J.E. Bennett (Eds.). Churchill Livingstone Inc., New York, 1993. 3-15.
11. Bush, K. Characterization of β-lactamases Antimicrob Agents Chemother 1989, 33: 259-63.
12. Gutmann, L., Kitzis, M.D., Acar, J.F. Evolution of enzymatic mechanisms of resistance among β-lactam antibiotics. J Int Med Res 1990, 18 (Suppl.4): 37-47D.
13. Murray, B.E. New aspects of antimicrobial resistance and the resulting therapeutic difemmas. J Infect Dis 1991, 163: 1185-94.
14. Murray, B.E. β-Lactamase-producingenterococci. Anlimicrob Agents Chemother 1992, 36: 2355-9.
15. Fontana, R., Aldegheri, M., Ligozzi, M., Lopez, H., Sucari, A., Satta, G. Overproduction of a low-affinity penicillin-binding protein and high level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1994, 38: 1980-3.
16. Hackbarth, C.J., Chambers, H.F Methicillin-resistant staphylococci: Genetics and mechanisms of resistance. Antimicrob Agents Chemother 1989, 33: 991-4.
17. Hideaki, H., Akagi, H., Masaru, S., Otani, T. Hyodo, A., Hiramitsu, K. TOC-39, a novel parenteral broad-specturm cephalosporin with excellent activity against methicillin-resistant Staphylococ-cus aureus. Antimicrob Agents Chemother 1995, 39: 1120-6.
18. Malouin, F., Bryan, L.E. Modification of penicillin-binding proteins as mechanisms of β-lactam resistance. Antimicrob Agents Chemother 1986, 30: 1-5.
19. Maple, P.A.C., Hamilton-Miller, J.M.T., Brumfitt, W. Worldwide antibiotic-resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989, 1: 537-40.
20. Neu, H.C. The crisis in antibiotic resistance. Science 1992, 257: 1064-73.
21. Hammond, S.M., Di Modugno, E., Lowther, J., Xerri, L., Gaviraghi, G GV118819 an orally absorbed prodrug ester of the tribactam GV104326. 32nd Intersci Conf Antimicrob Agents Chemother (Oct 11-14 Anaheim) 1992, Abst 130.
22. Di Modugno, E., Erbetti, I., Ferrari, L., Galassi, G., Hammond, S.M., Xerri, L. In vitro activity of the tribactam GV104326 against Gram-positive, Gram-negative, and anaerobic bacteria. Antimicrob Agents Chemother 1994, 38: 2362-8.
23. Singh, K.V., Coque, T.M., Murray, B.E. In vitro activity of the trinem sanfetrinem (GV104326) against Gram-positive organisms. Antimicrob Agents Chemother 1996. 40(9): 2142-6.
24. Spangler, S.K., Jacobs, M.R., Appelbaum, P.C. Antipneumococcal activity of sanfetrinem, a new oral trinem. compared to 11 βlactam and non-β-lactam agents. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18, New Orleans) 1996, Abst F150
25. Sifaoui, F., Duval, F., Boucot, L., Leblanc, F., Gutmann, L., Berche. P. In. vitro activity of sanfetrinem (GV104326) against bacterial isolates from acute otitis media (AOM) in children. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15 18, New Orleans) 1996, Abst F151.
26. Martinez-Beltrán, J., Valdezate, S., Cisterna, R., Basaras, M., Gobernado, M., Canton, E., Baquero, F. Antimicrobial profile of GV104326. a new tricyclic β-laciam antibiotic, in a multicenter study. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18. New Orleans) 1996, Abst F 152.
27. Thornsberry, C , Vanderhoof, B., Ogilvie, P., Gotten, C. The activity of GV 104326 (GV) compared to amoxicillin-clavulanic acid (AC) against selected pathogens. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18, New Orleans) 1996, Abst F153.
28. Lowther, J., Broggio, R., Hammond, S.M., Piccoli, L., Xerri, L. In vivo evaluation o! the tribactam GVW4326 and its orally absorbed prodrug ester GV1188I9. 18th Int Cong Chemother (June 27-July 2. Stockholm) 1993, Abst 490.
29. Di Modugno, E., Hammond, S.M., Lowther, J., Piccoli, L., Sabatini, D., Xerri, L. Activity of GV118819 against experimental bacterial respiratory tract infections. 33rd Intersci Conf Antimicrob Agents Chemother (Oct 17-20, New Orleans) 1993, Abst 923.
30. Andes, D., Vesga, O., Craig. W.A. Pharmacodynamicactivity of a tribactam in animal infection models. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18. New Orleans) 1996, Absl F154.
31. Wise, R., Andrews, J.M., Da Ros, L., Child, J., Mortiboy, D. A study of the pharmacokinetics and inflammatory fluid penetration of two doses of the hexetil prodrug of sanfetrinem. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18, New Orleans) 1996, Abst F155.
32. Lund, V.J., lavarone, L., Knight, S., Efthymiopoulos, C., Capriati, A.L. Sanfetrinem (GV104326) concentrations in sinus tissue following a single oral dose (as the prodrug GV118819X) in volunteer subjects. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18, New Orleans) 1996, Abst F156,
33. Capriati, A., Barrington, P., Gambini, F., Milleri, S., Patel, J., Pimazzoni, L., Baroldi, P. Safety and tolerability ofsingle and repeat doses of the new antibiotics GV104326 and GV118819 in healthy males 35th Intersci Conf Antimicrob Agents Chemother (Sept 17-20, San Francisco) 1995, Abst F139.